Digklia, A. http://orcid.org/0000-0001-7189-3035
Duran, R.
Homicsko, K.
Kandalaft, L. E.
Hocquelet, A.
Orcurto, A.
Coukos, G.
Denys, A.
Article History
Received: 26 March 2018
Accepted: 4 September 2018
First Online: 12 September 2018
Compliance with Ethical Standards
:
: G. Coukos reports grants from Bristol‐Myers‐Squibb, Roche, the National Institutes of Health, Celgene and Boehringer–Ingelheim; personal fees from Roche and Genentech; and support for clinical trials from Bristol‐Myers‐Squibb, Merck and Roche. A. Denys is a contracted consultant for BTG, Farnham, UK. Patent WO 2012/073188 A1 was issued and licensed to BTG by A. Denys. K. Homicsko reports grant from Roche and is a consultant/advisory board member for BMS, Merck Serono, Roche and AMGEN. L.E. Kandalaft reports that she is a consultant/advisory board member of Geneos. A. Digklia and A. Hocquelet have nothing to disclose. R. Duran reports grant from BTG.
: This article does not contain any studies with human participants or animals performed by any of the authors.